Haibin Wu1, Fangyuan Li1,2, Wei Shao1, Jianqing Gao1,3, Daishun Ling1,2,4. 1. Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P. R. China. 2. Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310012, P. R. China. 3. Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou 310058, P. R. China. 4. Key Laboratory of Biomedical Engineering of the Ministry of Education, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, P. R. China.
Abstract
Impaired diabetic wound healing represents a devastating and rapidly growing clinical problem associated with high morbidity, mortality, and recurrence rates. Engineering therapeutic angiogenesis in the wounded tissue is critical for successful wound healing. However, stimulating functional angiogenesis of the diabetic wound remains a great challenge, due to the oxidative damage and denaturation of bio-macromolecule-based angiogenic agents in the oxidative diabetic wound microenvironment. Here, we present a unique "seed-and-soil" strategy that circumvents the limitation by simultaneously reshaping the oxidative wound microenvironment into a proregenerative one (the "soil") and providing proangiogenic miRNA cues (the "seed") using an miRNA-impregnated, redox-modulatory ceria nanozyme-reinforced self-protecting hydrogel (PCN-miR/Col). The PCN-miR/Col not only reshapes the hostile oxidative wound microenvironment, but also ensures the structural integrity of the encapsulated proangiogenic miRNA in the oxidative microenvironment. Diabetic wounds treated with the PCN-miR/Col demonstrate a remarkably accelerated wound closure and enhanced quality of the healed wound as featured by highly ordered alignment of collagen fiber, skin appendage morphogenesis, functional new blood vessel growth, and oxygen saturation.
Impaired diabetic wound healing represents a devastating and rapidly growing clinical problem associated with high morbidity, mortality, and recurrence rates. Engineering therapeutic angiogenesis in the wounded tissue is critical for successful wound healing. However, stimulating functional angiogenesis of the diabetic wound remains a great challenge, due to the oxidative damage and denaturation of bio-macromolecule-based angiogenic agents in the oxidative diabetic wound microenvironment. Here, we present a unique "seed-and-soil" strategy that circumvents the limitation by simultaneously reshaping the oxidative wound microenvironment into a proregenerative one (the "soil") and providing proangiogenicmiRNA cues (the "seed") using an miRNA-impregnated, redox-modulatory ceria nanozyme-reinforced self-protecting hydrogel (PCN-miR/Col). The PCN-miR/Col not only reshapes the hostile oxidative wound microenvironment, but also ensures the structural integrity of the encapsulated proangiogenicmiRNA in the oxidative microenvironment. Diabetic wounds treated with the PCN-miR/Col demonstrate a remarkably accelerated wound closure and enhanced quality of the healed wound as featured by highly ordered alignment of collagen fiber, skin appendage morphogenesis, functional new blood vessel growth, and oxygen saturation.
Impaired diabetic wound
healing is the most common complication
in patients with diabetic hyperglycemia, which suffers from high morbidity,
mortality, and recurrence rates and is the leading cause of nontraumatic
limb amputations worldwide.[1,2] Increasing evidence
suggests that defective angiogenesis significantly contributes to
the debilitating conditions in impaired diabetic wound healing, which
limits the delivery of crucial oxygen and nutrient to the wounded
tissue thus impairing the wound healing process.[1,3,4] Furthermore, excessive oxidative stress
also plays a critical role in the pathology of impaired diabetic wound
healing.[5] Under this hostile wound microenvironment,
the uncontrolled accumulation of reactive oxygen species (ROS) leads
to significant destruction of endogenous stem cells, growth factors,
and nucleic acids in the wounded tissue and thus greatly compromises
their regenerative potential.[4,6−8] In addition, the externally administered proteins and nucleic acids
are also highly vulnerable in the harsh diabetic wound microenvironment.[6,9] Moreover, it is noteworthy that these two pathological factors,
defective angiogenesis and excessive oxidative stress, are not independent
of each other since excessive ROS has been proposed to restrict angiogenic
responses and result in endothelial dysfunction.[10,11] Current clinical therapies including debridement, antibiotics, blood-glucosecontrol, and living skin-equivalent grafts mainly focus on preventing
the expansion of the initial wound bed and infection.[12] Although symptom control maybe achieved by these standard
therapies, therapeutics for effectively regeneration of the diabetic
wound remains elusive. Unfortunately, ∼10% of diabetic wound
patients will eventually undergo limb amputation.[12,13]Among various efforts to address this urgent issue, reconstruction
of functional vascularity is of vital importance.[3,14] Despite significant advances being made in improving angiogenesis
in diabetic wounds by supplementing either angiogeniccells or growth
factors, the achievements made so far have failed to translate into
a meaningful clinical improvement because of a number of drawbacks.[15,16] A promising alternative to cells or growth factors for efficient
angiogenesis is miRNA,[17] a class of highly
conserved small noncoding regulatory RNAs, since accumulating evidence
has demonstrated that miRNAs are involved in the development of defective
angiogenesis.[18] Specifically, miR-26a has
been recently identified as a key negative regulator of angiogenesis
in diabetic wounds; inhibition of this miRNA may serve as a promising
therapeutic modality.[18] Remarkably, targeting
the disease-associated miRNA is a potentially more potent therapeutic
strategy in comparison with single-target angiogenic growth factors
since an individual miRNA with its pleiotropic effects can regulate
multiple different genes and processes.Although various nonviral
or viral vectors have been explored for
delivering these promising miRNAs in inhibition and replacement therapies,[19,20] an insurmountable obstacle is their rapid breakdown and inactivation
in the hostile disease microenvironment,[9] which in the case of the diabetic wound, is the excessive oxidative
stress.[6] Nevertheless, in addition to the
diabetic wound, excessive ROS are also tightly linked with a myriad
of serious diseases, where miRNAs could serve as promising therapeutic
approaches.[21] Unfortunately, to the best
of our knowledge, studies devoted to the design and construction of
highly efficient miRNA carriers with a self-protecting capacity in
the hostile oxidative disease microenvironment have been rarely reported
so far. Meanwhile, engineering a friendly wound microenvironment is
increasingly recognized as a novel paradigm for the successful healing
of diabetic wound.[5,6] Accordingly, materials designed
to simultaneously deliver proangiogenicmiRNA cues (the “seed”)
in a self-protecting manner and reshape the hostile oxidative wound
microenvironment (the “soil”) are therefore highly desired
yet challenging for functional angiogenesis and regenerative diabetic
wound healing.Recent advances in nanotechnology for biomedical
applications have
enabled elegant solutions for these problems.[22] As a representative nanozyme, ceria nanocrystals have recently drawn
great attention in the treatment of oxidative-stress-associated diseases
due to their facile synthesis, excellent biocompatibility, superior
multiple antioxidant enzyme-mimetic activity, and rejuvenated catalytic
performance.[23,24] These beneficial intrinsic properties
of ceria nanozyme make it superior to other conventional antioxidant
molecules or enzymes since they usually suffer from respective and
collective drawbacks such as poor stability, high cost, scavenging
only a single type of ROS, and nonrenewable ROS-scavenging capacity.[25] Furthermore, in comparison with the systemic
administration route, we hypothesize that topical miRNA delivery by
an miRNA-containing hydrogel depot may be favorable for their therapeutic
effects in a site-specific manner, without raising concerns about
systemictoxicity and off-target side effects.[26−28] On the basis
of these considerations, herein we introduce a unique “seed-and-soil”
strategy for enhanced diabetic wound healing using a nanozyme-reinforced
self-protecting hydrogel (PCN-miR/Col) composed of 25 kDa polyethylenimine
(PEI25K) functionalized ceria nanocluster (PCN) antagomiR-26a
(miR) nanocomplex (PCN-miR), which is designed to simultaneously reshape
the hostile wound microenvironment (the “soil”) and
provide proangiogeniccues (the “seed”) for diabetic
wound repair and regeneration (Figure A,B). The natural extracellular matrix protein collagen
was employed for the construction of the hydrogel, which serves as
a favorable platform for the integration of the PCN-miR. AntagomiR-26a
was utilized to inhibit the antiangiogenicmiR-26a, a well-established
hyperglycemia-induced target that is responsible for impaired angiogenesis
in diabetic wounds.[18] Benefited from the
highly efficient ROS-scavenging activities, PCN-miR/Col not only enable
reformation of the hostile oxidative wound microenvironment, but also
protect the encapsulated miRNAs against ROS-induced damage. Because
of the extraordinary synergy, augmented functional blood vessel growth
and oxygen saturation were achieved, resulting in an accelerated wound
closure and a superior quality of the newly healed wound featured
by ordered alignment of collagen fiber and skin appendage morphogenesis.
The proposed “seed-and-soil” strategy is applicable
to the repair and regeneration of a broad range of damaged tissues,
which suffer from highly oxidative diseased microenvironments and
dysregulated bio-macromolecules.
Figure 1
Schematic illustration of the fabrication
process for the PCN-miR/Col
hydrogel, and the strategy for functional angiogenesis and regenerative
diabetic wound healing. (A) Schematic illustration of the fabrication
routes for PCN-miR/Col. (B) Schematic illustration of the PCN-miR/Col-enabled
strategy for simultaneous self-protecting delivery of proangiogenic
miRNA cues and creation of proregenerative wound microenvironment
to drive highly efficient functional angiogenesis and regenerative
diabetic wound healing.
Schematin>an class="Chemical">c illustration of the fabrication
process for the PCN-miR/Col
hydrogel, and the strategy for functional angiogenesis and regenerative
diabetic wound healing. (A) Schematic illustration of the fabrication
routes for PCN-miR/Col. (B) Schematic illustration of the PCN-miR/Col-enabled
strategy for simultaneous self-protecting delivery of proangiogenicmiRNA cues and creation of proregenerative wound microenvironment
to drive highly efficient functional angiogenesis and regenerative
diabetic wound healing.
Results and Discussion
Fabrication of PCN-miR/Col Hydrogel and Resistance
to Oxidative
Denaturation
The facile process to fabricate PCNs begins
with the synthesis of ultrasmall (∼3 nm in diameter) ceria
nanozymes (Figure S1A),[23] followed by surface modification with PEI25K. The PCN-miR was subsequently prepared by electrostatic interaction
between negatively charged antagomiR-26a and positively charged PCNs.
The intimate contact of ceria nanozyme and miRNA enabled by covalent
modification of ceria nanozyme with PEI25K allows an all-weather
protection of impregnated miRNA against oxidative damage, which is
advantageous over simple combination or sequential delivery of ceria
nanozyme and PEI25k-miRNA complex. As shown in the transmission
electron microscopy (TEM) image, the prepared PCN-miR has a size of
∼20 nm (Figure A, Figure S1B,C). An increased N:P ratio
led to a smaller size and more positive charge of PCN-miR, as revealed
by dynamic light scattering (DLS) and ζ-potential measurements
(Figure S1D,E). The agarose gel retardation
assay indicates that antagomiR-26a binds to PCNs with a N:P ratio
(the ratio of nitrogen in PEI25K to the phosphorus in antagomiR-26a)
>5 (Figure S1F). Notably, there
is
no significant change in the DLS size and ζ-potential of PCN-miR
when the N:P ratio is greater than 10, whereas severe cytotoxicitycould be induced at higher N:P ratios.[29] Therefore, a N:P ratio of 10 was chosen for the further experiments.
Figure 2
Characterization
of PCN-miR/Col hydrogel and their resistance to
oxidative denaturation. (A) TEM image of PCN-miR. Scale bar, 50 nm.
(B) SEM image of the surface of PCN-miR/Col (inset: digital photograph
of PCN-miR/Col hydrogel). The PCN-miR (marked by yellow solid circles)
was clearly observed. Scale bar, 1 μm. (C) Three-dimensional
confocal laser scanning microscopy (CLSM) image of PCN-miR/Col, where
collagen from the hydrogel is labeled with fluorescein isothiocyanate
(green), and antagomiR-26a is tagged with Cy5 (red). Scale bar, 100
μm. (D) AFM phase image of PCN-miR/Col. Scale bar, 500 nm. (E)
Schematic illustration of the responses of collagen-based hydrogels
under ROS exposure. Confocal Raman mapping of collagen-based hydrogels
before (upper panel) and after (lower panel) exposure to H2O2: (F) the 1280 cm–1 peak corresponds
to the amide III from collagen, and (G) the 810 cm–1 peak corresponds to the backbone O-P-O stretching from antagomiR-26a.
Scale bars, 20 μm. (H) Deconvoluted high-resolution C1s XPS
and (I) CD spectra of collagen-based hydrogels with or without exposure
to H2O2. The XPS spectra were fitted to four
energy components centered at around 284.6 (C-C/C-H), 285.5 (C-O/C-N),
287.8 (N-C=O), and 288.6 (O-C=O) eV.
Characterization
of PCN-miR/Col hydrogel and their resistance to
oxidative denaturation. (A) TEM image of PCN-miR. Scale bar, 50 nm.
(B) SEM image of the surface of PCN-miR/Col (inset: digital photograph
of PCN-miR/Col hydrogel). The PCN-miR (marked by yellow solid circles)
was clearly observed. Scale bar, 1 μm. (C) Three-dimensional
confocal laser scanning microscopy (CLSM) image of PCN-miR/Col, where
collagen from the hydrogel is labeled with fluorescein isothiocyanate
(green), and antagomiR-26a is tagged with Cy5 (red). Scale bar, 100
μm. (D) AFM phase image of PCN-miR/Col. Scale bar, 500 nm. (E)
Schematic illustration of the responses of collagen-based hydrogels
under ROS exposure. Confocal Raman mapping of collagen-based hydrogels
before (upper panel) and after (lower panel) exposure to H2O2: (F) the 1280 cm–1 peak corresponds
to the amide III from collagen, and (G) the 810 cm–1 peak corresponds to the backbone O-P-O stretching from antagomiR-26a.
Scale bars, 20 μm. (H) Deconvoluted high-resolution C1s XPS
and (I) CD spectra of collagen-based hydrogels with or without exposure
to H2O2. The XPS spectra were fitted to four
energy components centered at around 284.6 (C-C/C-H), 285.5 (C-O/C-N),
287.8 (N-C=O), and 288.6 (O-C=O) eV.The gelation kinetics of the PCN-miR/Col were monitored
(Figure S2A).[30] From
the scanning electron microscopy (SEM) images, the surfaces of naked
antagomiR-26a-loaded (miR-loaded) collagen hydrogel (miR/Col) and
PEI25k (P) antagomiR-26a (miR) complex-doped collagen hydrogel
(P-miR/Col) are clean and smooth, while the surface of PCN-miR/Col
is homogeneously doped with PCN-miR (Figure B, Figure S2B).
Furthermore, energy-dispersive X-ray (EDX) elemental mapping results
clearly indicate the uniform existence of C, N, S, and Ce elements
in PCN-miR/Col (Figure S2C). Fluorescently
labeled antagomiR-26a within the P-miR/Col and PCN-miR/Col demonstrates
a good distribution uniformity due to the electrostatic repulsion
elicited by the PEI25K polycations, whereas an evident
aggregation was observed in the matrix of the miR/Col (Figure C, Figure S2D). Compared to the soft property of the polymer in miR/Col
and P-miR/Col, the metallicceria nanozymes in the PCN-miR/Col exhibited
the stiffness as demonstrated by the atomic force microscopy (AFM)
phase images (Figure D, Figure S2E).Recent studies indicate
that hydrogen peroxide (H2O2) is overproduced
in diabetic complications and can convert
to various highly reactive radicals;[31,32] therefore,
we employed H2O2 to simulate the oxidative stress
microenvironment. The influence of H2O2 exposure
on the structural and conformational integrity of the incorporated
antagomiR-26a and collagen matrix was further investigated (Figure E). A significant
decrease in Raman signals for collagen and antagomiR-26a was detected
after exposure of miR/Col and P-miR/Col to ROS, whereas only a slight
change of the Raman signals was detected on the ceria nanozyme-doped
PCN-miR/Col (Figure F,G). These changes in Raman features clearly indicated the denaturation
of the collagen matrix and antagomiR-26a in miR/Col and P-miR/Col,
whereas the structural integrity of these bioactive macromolecules
was largely preserved in PCN-miR/Col, suggesting that incorporated
ROS-scavenging ceria nanozymes could mitigate the consequences of
oxidative damage.[23,33] This is a highly desired property
for application of bio-macromolecule-based therapeutics, since proteins
and nucleic acids are generally prone to denature in highly oxidative
conditions.[34]In accordance with
the Raman mapping results, the deconvoluted
high-resolution C1s X-ray photoelectron spectra (XPS) displayed an
obvious new peak at around 288.6 eV corresponding to the O-C=O
bond, while the peak corresponding to the N-C=O bond (287.8
eV) decreased notably in miR/Col and P-miR/Col after ROS exposure,
indicating that the N-C=O bonds in the collagen matrix cleave
upon oxidative damage (Figure H). Furthermore, although a small new peak corresponding to
the O-C=O bond was also observed, C1s XPS spectra of PCN-miR/Col
did not change significantly before and after ROS exposure, which
confirms the lack of a drastic denaturing process (Figure H). Circular dichroism (CD)
spectra were obtained before and after ROS exposure, which are highly
sensitive to three-dimensional conformations of proteins.[35] Before ROS exposure, the collagen hydrogels
showed a similar triple-helical CD signal pattern with a positive
peak at 220-221 nm and a negative peak at 197-198 nm, suggesting that
the incorporation of antagomiR-26a and ceria nanozymes had a negligible
influence on the secondary structures of collagen proteins (Figure I). Subjecting the
miR/Col and P-miR/Col hydrogels to ROS resulted in a sharp decrease
in negative ellipticity (Figure I). By contrast, PCN-miR/Col exhibited only a minimal
decrease in the negative CD signal after ROS exposure, confirming
greater stability of the helical structure in the collagen matrix
(Figure I). Collectively,
these results support the concept that incorporation of ceria nanozymes
endows the collagen hydrogel with resistance to oxidative damage,
which can greatly enhance the efficacy of the fragile antagomiR-26a
for diabetic wound healing in the highly oxidative wound bed.
PCN-miR/Col
Protects Cells against Harmful Oxidative Damage
The biocompn>atibility
is a prerequisite for biomedical applications.
As shown in Figure S3A,B, PCNs and PCN-miR
had no obvious cytotoxicitycompared with PEI25k and PEI25k (P) antagomiR-26a (miR) complex (P-miR), indicating that
functionalization of PEI25k with ceria nanozymes did not
result in additional toxicity. In addition, the cytotoxicity of PCN
was lower than that of PEI25k, indicating that the increased
generation of ROS by PEI25k can be scavenged by the ceria
nanozyme.[36] We further explored the cell
uptake behaviors by confocal laser scanning microscopy (CLSM) using
a fluorescently (Cy5) labeled antagomiR-26a. The human umbilical vein
endothelial cells (HUVECs) exhibited a much stronger fluorescence
signal of antagomiR-26a after incubation with PCN-miRcompared to
that generated after incubation with P-miRcomplexes or
naked antagomiR-26a (Figure S3C). Since
both PCN-miR and P-miRcontain PEI25K polycations, this
discrepancy in cellular uptake arises from the ceria nanozymes, which
is consistent with many previous reports using inorganic nanoparticles
as carriers for nucleic acids.[37] Furthermore,
the CLSM images clearly revealed no obvious change in cell viability
after 4 days of incubation with the PCN-miR/Col hydrogel, indicating
that the PCN-miR/Col hydrogel is highly biocompatible (Figure S3D). We next evaluated whether this redox-active
nanocomposite hydrogel could protect cells and intracellular bio-macromolecules
against harmful oxidative damage. HUVECs were preincubated with the
hydrogels and then challenged with H2O2 to simulate
an oxidative microenvironment. HUVECs preincubated with miR/Col or
P-miR/Col exhibited significant cell mortality upon oxidative stress,
whereas the PCN-miR/Col group showed only minimal reduction in cell
viability (Figure A). The ceria nanozymes incorporating PCN-miR/Col significantly boosted
the extent of ROS-scavenging, with the greatest reduction in mean
cell fluorescence of the ROS probe 2′-7′-dichorofluorescein
(DCF) (Figure S4A). These results were
further confirmed by CLSM observations (Figure B, Figure S4B).
Figure 3
Incubation
with the PCN-miR/Col confers robust protection to ROS-exposed
cells. (A) Pretreatment of HUVECs with PCN-miR/Col abrogated H2O2-induced cell viability loss as indicated by
live/dead staining with calcein-AM (green) and propidium iodide (red).
Scale bars, 50 μm. (B) Representative CLSM images showing the
H2O2-induced intracellular ROS accumulation
in HUVECs with various pretreatments, using DCF-DA as an ROS indicator.
Scale bars, 50 μm. Representative confocal images of (C) JC-1
(a mitochondrial membrane potential-sensitive probe) and (D) γ-H2AX
(a marker of DNA double-strand breaks) staining in cells with various
pretreatments after exposure to H2O2. Scale
bars, 20 μm. (E) Lipid peroxidation product MDA and (F) protein
carbonylation levels in cells with various pretreatments after exposure
to H2O2. All results are presented as mean ±
SD, *P < 0.05 by two-tailed unpaired Student’s t tests, n = 3. (G) Schematic illustration
of the ROS-induced damage responses in cells cultured on collagen-based
hydrogels.
Incubation
with the PCN-miR/Col confers robust protection to ROS-exposed
cells. (A) Pretreatment of HUVECs with PCN-miR/Col abrogated H2O2-induced cell viability loss as indicated by
live/dead staining with calcein-AM (green) and propidium iodide (red).
Scale bars, 50 μm. (B) Representative CLSM images showing the
H2O2-induced intracellular ROS accumulation
in HUVECs with various pretreatments, using DCF-DA as an ROS indicator.
Scale bars, 50 μm. Representative confocal images of (C) JC-1
(a mitochondrial membrane potential-sensitive probe) and (D) γ-H2AX
(a marker of DNA double-strand breaks) staining in cells with various
pretreatments after exposure to H2O2. Scale
bars, 20 μm. (E) Lipid peroxidation product MDA and (F) protein
carbonylation levels in cells with various pretreatments after exposure
to H2O2. All results are presented as mean ±
SD, *P < 0.05 by two-tailed unpaired Student’s t tests, n = 3. (G) Schematic illustration
of the ROS-induced damage responses in cells cultured on collagen-based
hydrogels.Subcellular components are highly
susceptible to ROS-induced oxidative
damage, resulting in their functional impairment. We next examined
the impact of PCN-miR/Col on the responses of subcellular components
to toxicROS. After H2O2 exposure, cells pretreated
with miR/Col or P-miR/Col displayed reduced mitochondrial polarization
(as determined by the 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imidacarbocyanine
(JC-1) aggregate:monomer ratio) compared to cells pretreated with
PCN-miR/Col (Figure C, Figure S4C). The level of double-stranded
DNA damage was determined with immunofluorescence of phosphorylated
H2A histone family member X (γ-H2AX). Compared to miR/Col or
P-miR/Col pretreatment, cells pretreated with PCN-miR/Col showed significantly
diminished accumulation of DNA damage foci after oxidative insult
(Figure D, Figure S4D). Similar differential behaviors in
the contents of the lipid peroxidation product malondialdehyde (MDA)
and carbonylated proteins were also detected among the groups upon
H2O2 exposure, thus further supporting that
PCN-miR/Col could attenuate the oxidative damage of these subcellular
components (Figure E,F). Collectively, these data demonstrated that the ROS-modulating
hydrogel PCN-miR/Col confers robust cellular protection against ROS
accumulation (Figure G). Previous studies have shown that cells exposed to the oxidative
microenvironment exhibited enhanced cellular senescence, leading to
the impairment for functional angiogenesis and tissue regeneration.[38] Indeed, because of their limited capabilities
in ROS-scavenging, the miR/Col- or P-miR/Col-pretreated cells challenged
with H2O2 acquired a significant senescent phenotype
with high levels of senescence-associated β-galactosidase (SA-β-gal)
activity in comparison to those pretreated with PCN-miR/Col (Figure S4E).
PCN-miR/Col Reshapes the
Wound Microenvironment and Corrects
miR-26a Overexpression
We next explored the therapeutic effect
of these collagen-based hydrogels in a streptozotocin-induced (STZ-induced)
diabetic wound rat model. Diabetic excisional wounds were created
in STZ-induced diabeticrats, which were topically treated with a
series of collagen hydrogels: (i) collagen hydrogel alone (Col), (ii)
P-miR/Col, (iii) PCN-loaded collagen hydrogel (PCN/Col), (iv) PCN-scrambled
miRNA (scR) nanocomplex (PCN-scR) loaded collagen hydrogel (PCN-scR/Col),
and (v) PCN-miR/Col. Immunofluorescence staining of wound tissues
displayed increased amounts of oxidative DNA damage marker 8-hydroxydeoxyguanosine
(8-OHdG) after treatments with the hydrogels without containing ceria
nanozymes (Col and P-miR/Col) and the blank control, whereas much
lower 8-OHdG levels were detected in the wounds of diabeticrats treated
with hydrogels loaded with the ceria nanozymes (PCN/Col, PCN-scR/Col,
and PCN-miR/Col) (Figure A). Similar differential results in the contents of the lipid
peroxidation marker 4-hydroxy-2-nonenal (4-HNE) were also observed
(Figure B). Notably,
the skin tissues from diabeticrats, but not from healthy rats, presented
robust oxidative damage signals (8-OHdG and 4-HNE) and insufficient
proliferation markers Ki67 (Figure S5).
Figure 4
In vivo topical application of PCN-miR/Col reshapes
the highly oxidative and inflammatory wound microenvironment and corrects
miR-26a overexpression. Representative confocal images of immunofluorescence
staining and quantification for (A) 8-OHdG (a marker of oxidative
DNA damage), (B) 4-HNE (a marker of lipid peroxidation), (C) CD68-positive
macrophages, (D) miR-26a, and (E) Ki67-positive cells in sections
from each group after 28 days of treatment (n = 4).
Scale bars for 8-OHdG, 4-HNE, CD68, and Ki67 images, 50 μm;
Scale bars for miR-26a image, 100 μm. All results are presented
as mean ± SD, *P < 0.05 by two-tailed unpaired
Student’s t tests.
In vivo topical application of PCN-miR/Col reshapes
the highly oxidative and inflammatory wound microenvironment and corrects
miR-26a overexpression. Representative confocal images of immunofluorescence
staining and quantification for (A) 8-OHdG (a marker of oxidative
DNA damage), (B) 4-HNE (a marker of lipid peroxidation), (C) CD68-positive
macrophages, (D) miR-26a, and (E) Ki67-positive cells in sections
from each group after 28 days of treatment (n = 4).
Scale bars for 8-OHdG, 4-HNE, CD68, and Ki67 images, 50 μm;
Scale bars for miR-26a image, 100 μm. All results are presented
as mean ± SD, *P < 0.05 by two-tailed unpaired
Student’s t tests.Studies have revealed that continued oxidative stress can
lead
to unresolved inflammation.[1] As an efficient
antioxidant agent, ceria nanozyme demonstrated excellent anti-inflammation
effect.[39] Robust infiltration of CD68-positive
monocytes/macrophages was clearly observed in wound tissues treated
with hydrogels without containing ceria nanozymes (Col and P-miR/Col)
and the blank control, while substantially milder infiltration of
monocytes/macrophages was detected in the wounds treated with ceria
nanozyme-loaded hydrogels (PCN/Col, PCN-scR/Col, and PCN-miR/Col)
(Figure C). Wounds
treated with PCN-miR/Col displayed only a modest miR-26a signal, while
intensive fluorescence of miR-26a was detected in wound tissues treated
with the other groups (Figure D). The failure of P-miR/Col to inhibit miR-26acan be attributed
to the lack of protection for antagomiR-26a against the highly oxidative
microenvironment. Furthermore, wounds treated with PCN-miR/Col had
a markedly higher frequency of the proliferation marker Ki67-expressing
cells in comparison to those of the other groups (Figure E). Collectively, these findings
suggested that the PCN-miR/Col hydrogel was endowed with the capacity
to reshape the highly oxidative wound microenvironment and miR-26a
overexpression.
PCN-miR/Col Induces Accelerated and Regenerative
Diabetic Wound
Healing
The PCN-miR/Col treatment group displayed significantly
faster wound closure than that of the other five groups (Figure A). Wounds treated
with PCN-miR/Col exhibited a smooth yellowish appearance, like healthy
skin, whereas wounds treated with other groups displayed an ulcerative
reddish surface (Figure S6). Staining of
wound sections with Masson’s trichrome revealed a significant
increase in collagen fiber density and marked regeneration of skin
appendages in the PCN-miR/Col-treated wounds (Figure B). SEM imaging demonstrated
a highly ordered alignment of collagen fiber in the PCN-miR/Col-treated
wounds, whereas the collagen fibers from the wounds of control groups
were more disarranged and tangled (Figure S7). Picrosirius red staining further confirmed increased collagen
deposition in PCN-miR/Col-treated wounds with a predominantly yellow–orange
(collagen I) appearance in comparison to wounds treated with other
groups, which mainly showed smaller green collagen fibers (collagen
type III) (Figure S8). Remarkably, the
intact diabetic skin and nondiabetic skin also displayed a highly
ordered collagen fiber alignment with predominant yellow–orange
staining (collagen type I) (Figure S9A).
The type I/III collagen ratio in the PCN-miR/Col-treated wounds was
significantly increased compared with those of other groups (Figure S9B). The relatively high type I/III collagen
ratio indicates successful collagen maturation and enhanced mechanical
strength of the healed wound tissue, which would make the wound more
resistant to reinjury.[40] In addition, H&E
staining demonstrated no significant toxicity in the major organs
of the treated rats (Figure S10).[41]
Figure 5
PCN-miR/Col induces accelerated and regenerative diabetic
wound
healing in vivo. (A) Digital images of wounds at
day 0, 4, and 10 after the indicated treatment (left panel) and quantification
of wound closure as a percentage of the initial wound area (right
panel, n = 5). (B) Masson’s trichrome staining
of representative wound tissues from each group after 28 days of treatment.
Scale bars, 100 μm. (C) Representative confocal images of VEGF
and CD31 double-stained sections and quantification for VEGF expression
and number of blood vessels per high-powered field (HPF) from each
group at day 28. Scale bars, 50 μm. n = 4.
(D) Photoacoustic images and quantification for oxygenated hemoglobin
from each group at day 28. Scale bars, 1 mm. n =
3. All results are presented as mean ± SD, *P < 0.05 by two-tailed unpaired Student’s t tests.
PCN-miR/Col induces accelerated and regenerative diabetic
wound
healing in vivo. (A) Digital images of wounds at
day 0, 4, and 10 after the indicated treatment (left panel) and quantification
of wound closure as a percentage of the initial wound area (right
panel, n = 5). (B) Masson’s trichrome staining
of representative wound tissues from each group after 28 days of treatment.
Scale bars, 100 μm. (C) Representative confocal images of VEGF
and CD31 double-stained sections and quantification for VEGF expression
and number of blood vessels per high-powered field (HPF) from each
group at day 28. Scale bars, 50 μm. n = 4.
(D) Photoacoustic images and quantification for oxygenated hemoglobin
from each group at day 28. Scale bars, 1 mm. n =
3. All results are presented as mean ± SD, *P < 0.05 by two-tailed unpaired Student’s t tests.As shown in Figure C, diabetic wounds treated with PCN-miR/Col
displayed pronounced
VEGF expression and blood vessel formation in comparison to those
of the other groups. The function of these newly formed blood vessels
was further examined using a high-frequency ultrasound and photoacoustic
microimaging system. Interestingly, a significantly higher proportion
of oxygenated hemoglobin was observed in the wound tissues treated
with PCN-miR/Col compared to the other treatments, suggesting that
PCN-miR/Col resulted in marked improvement in the oxygen supply (Figure D). Collectively,
these data indicated that structural and functional blood vessels
were successfully re-established in PCN-miR/Col-treated diabetic wounds.
Conclusions
In summary, we adopted the “seed-and-soil”
concept
in the regenerative medicine field to guide the design of biomaterials
for addressing the underlying pathological mechanisms of impaired
diabetic wound healing.[2,6] To simultaneously provide a proregenerative
wound microenvironment (the “soil”) and proangiogeniccues (the “seed”) for diabetic wound repair and regeneration,
we developed PCN-miR/Col, an antagomiR-26a-impregnated redox-active
self-protecting hydrogel. As a proof of concept, we demonstrate that
the PCN-miR/Col can protect the incorporated proangiogenic antagomiR-26a
from denaturation by ROS exposure and efficiently alleviate oxidative
damage both in vitro and in vivo. Immunofluorescence and photoacoustic imaging analyses further reveal
that PCN-miR/Col markedly promotes the vascular regeneration and oxygen
supply in the wound bed. As a result, the PCN-miR/Col treatment yielded
significantly improved diabetic wound repair and regeneration with
an accelerated wound healing rate, marked regeneration of skin appendages,
and enhanced collagen deposition in the wound bed. To the best of
our knowledge, our study represents the first demonstration of a multifunctional
hydrogel, which offers both the proregenerative wound microenvironment
(the microenvironmental cues, “soil”) and proangiogenicmiRNAs (the biochemical cues, “seed”) for functional
angiogenesis and regenerative diabetic wound healing.
Authors: Ralf A Benndorf; Edzard Schwedhelm; Anke Gnann; Raihana Taheri; Ghainsom Kom; Michael Didié; Anna Steenpass; Süleyman Ergün; Rainer H Böger Journal: Circ Res Date: 2008-09-18 Impact factor: 17.367
Authors: Shuoran Li; Lina R Nih; Haylee Bachman; Peng Fei; Yilei Li; Eunwoo Nam; Robert Dimatteo; S Thomas Carmichael; Thomas H Barker; Tatiana Segura Journal: Nat Mater Date: 2017-08-07 Impact factor: 43.841
Authors: Alexander B Shcherbakov; Vladimir V Reukov; Alexander V Yakimansky; Elena L Krasnopeeva; Olga S Ivanova; Anton L Popov; Vladimir K Ivanov Journal: Polymers (Basel) Date: 2021-03-17 Impact factor: 4.329